Literature DB >> 22253420

Early postnatal hyperalimentation impairs renal function via SOCS-3 mediated renal postreceptor leptin resistance.

Miguel Angel Alejandre Alcazar1, Eva Boehler, Eva Rother, Kerstin Amann, Christina Vohlen, Stephan von Hörsten, Christian Plank, Jörg Dötsch.   

Abstract

Early postnatal hyperalimentation has long-term implications for obesity and developing renal disease. Suppressor of cytokine signaling (SOCS) 3 inhibits phosphorylation of signal transducer and activator of transcription (STAT) 3 and ERK1/2 and thereby plays a pivotal role in mediating leptin resistance. In addition, SOCS-3 is induced by both leptin and inflammatory cytokines. However, little is known about the intrinsic-renal leptin synthesis and function. Therefore, this study aimed to elucidate the implications of early postnatal hyperalimentation on renal function and on the intrinsic-renal leptin signaling. Early postnatal hyperalimentation in Wistar rats during lactation was induced by litter size reduction at birth (LSR) either to LSR10 or LSR6, compared with home cage control male rats. Assessment of renal function at postnatal day 70 revealed decreased glomerular filtration rate and proteinuria after LSR6. In line with this impairment of renal function, renal inflammation and expression as well as deposition of extracellular matrix molecules, such as collagen I, were increased. Furthermore, renal expression of leptin and IL-6 was up-regulated subsequent to LSR6. Interestingly, the phosphorylation of Stat3 and ERK1/2 in the kidney, however, was decreased after LSR6, indicating postreceptor leptin resistance. In accordance, neuropeptide Y (NPY) gene expression was down-regulated; moreover, SOCS-3 protein expression, a mediator of postreceptor leptin resistance, was strongly elevated and colocalized with NPY. Thus, our findings not only demonstrate impaired renal function and profibrotic processes but also provide compelling evidence of a SOCS-3-mediated intrinsic renal leptin resistance and concomitant up-regulated NPY expression as an underlying mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253420     DOI: 10.1210/en.2011-1670

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Early life obesity and chronic kidney disease in later life.

Authors:  Hyung Eun Yim; Kee Hwan Yoo
Journal:  Pediatr Nephrol       Date:  2014-08-22       Impact factor: 3.714

2.  Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice.

Authors:  Katharina Dinger; Philipp Kasper; Eva Hucklenbruch-Rother; Christina Vohlen; Eva Jobst; Ruth Janoschek; Inga Bae-Gartz; Silke van Koningsbruggen-Rietschel; Christian Plank; Jörg Dötsch; Miguel Angel Alejandre Alcázar
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

Review 3.  Developmental Programming of Renal Function and Re-Programming Approaches.

Authors:  Eva Nüsken; Jörg Dötsch; Lutz T Weber; Kai-Dietrich Nüsken
Journal:  Front Pediatr       Date:  2018-02-27       Impact factor: 3.418

4.  Renal Programming by Transient Postnatal Overfeeding: The Role of Senescence Pathways.

Authors:  Christian Juvet; Benazir Siddeek; Catherine Yzydorczyk; Catherine Vergely; Katya Nardou; Jean-Baptiste Armengaud; Mohamed Benahmed; Umberto Simeoni; François Cachat; Hassib Chehade
Journal:  Front Physiol       Date:  2020-05-25       Impact factor: 4.566

Review 5.  Programming of Cardiovascular Dysfunction by Postnatal Overfeeding in Rodents.

Authors:  Marie Josse; Eve Rigal; Nathalie Rosenblatt-Velin; Luc Rochette; Marianne Zeller; Charles Guenancia; Catherine Vergely
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

6.  Postnatal overfeeding causes early shifts in gene expression in the heart and long-term alterations in cardiometabolic and oxidative parameters.

Authors:  Ahmed Habbout; Charles Guenancia; Julie Lorin; Eve Rigal; Céline Fassot; Luc Rochette; Catherine Vergely
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.